ConductScience.org, home

Paper39247341

Nanoparticle-mediated gene delivery of TRAIL to resistant cancer cells: A review.

Habibizadeh M and 4 others. Heliyon, 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Nanoparticle-mediated gene delivery of TRAIL to resistant cancer cells: A review. Papers, record 39247341. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39247341

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Nanoparticle-mediated gene delivery of TRAIL to resistant cancer cells: A review.
PubMed
Journal
Heliyon
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.64, provisional
iCite
Revised in PubMed
2024-09-10
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Habibizadeh MMina
2Lotfollahzadeh SShima
3Mahdavi PParisa
4Mohammadi SSoheila
5Tavallaei OOmid

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References119

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128290155Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment.Top Curr Chem (Cham)2017https://conductscience.org/library/papers/28290155PubMed
229859281The proton sponge hypothesis: Fable or fact?Eur J Pharm Biopharm2018https://conductscience.org/library/papers/29859281PubMed
332112851Autophagy inhibition changes the disposition of non-viral gene carriers during blood-brain barrier penetration and enhances TRAIL-induced apoptosis in brain metastatic tumor.J Control Release2020https://conductscience.org/library/papers/32112851PubMed
428140697PTEN and TRAIL genes loaded zein nanoparticles as potential therapy for hepatocellular carcinoma.J Drug Target2017https://conductscience.org/library/papers/28140697PubMed
522648524Branched and linear poly(ethylene imine)-based conjugates: synthetic modification, characterization, and application.Chem Soc Rev2012https://conductscience.org/library/papers/22648524PubMed
631333662Multiple Interactions Between Cancer Cells and the Tumor Microenvironment Modulate TRAIL Signaling: Implications for TRAIL Receptor Targeted Therapy.Front Immunol2019https://conductscience.org/library/papers/31333662PubMed
733942822Magnetic nanocomplexes for gene delivery applications.J Mater Chem B2021https://conductscience.org/library/papers/33942822PubMed
812660816Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells.Oncogene2003https://conductscience.org/library/papers/12660816PubMed
916373718Chemotherapy and TRAIL-mediated colon cancer cell death: the roles of p53, TRAIL receptors, and c-FLIP.Mol Cancer Ther2005https://conductscience.org/library/papers/16373718PubMed
1031550511Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment.Int J Pharm2020https://conductscience.org/library/papers/31550511PubMed
1137065863Nano-TRAIL: a promising path to cancer therapy.Cancer Drug Resist2023https://conductscience.org/library/papers/37065863PubMed
1224076237TRAIL on trial: preclinical advances in cancer therapy.Trends Mol Med2013https://conductscience.org/library/papers/24076237PubMed
1332718904TRAIL of Hope Meeting Resistance in Cancer.Trends Cancer2020https://conductscience.org/library/papers/32718904PubMed
1429172759Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.Drug Deliv2017https://conductscience.org/library/papers/29172759PubMed
1511479629Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.Nat Med2001https://conductscience.org/library/papers/11479629PubMed
1625555748Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery.Drug Discov Today2015https://conductscience.org/library/papers/25555748PubMed
1722407575Resistance to TRAIL and how to surmount it.Immunol Res2012https://conductscience.org/library/papers/22407575PubMed
1836594589Fluorescent Self-Reporting Lipid Nanoparticles for Nitric Oxide/Gene Co-Delivery and Combination Therapy.Mol Pharm2023https://conductscience.org/library/papers/36594589PubMed
1912215894Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.Gene Ther2002https://conductscience.org/library/papers/12215894PubMed
2021306770Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles.Biomaterials2011https://conductscience.org/library/papers/21306770PubMed

See all 119 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42835823The Nanoparticle Delivery Gap in Immune Cell Engineering: From Uptake to Endosomal Escape.Int J Nanomedicine2026https://conductscience.org/library/papers/42835823PubMed
42587825Graphene Oxide Modulates ROS Production and Apoptotic Responses to Bortezomib in Human Glioblastoma Cells: An In Vitro Study.Cells2026https://conductscience.org/library/papers/42587825PubMed
40530018Current trends in theranostic applications of extracellular vesicles in cancer.Front Oncol2025https://conductscience.org/library/papers/40530018PubMed
40390226Porphyrin-based MOFs for Gene Delivery in Cancer Therapy: Recent Advances and Progress.Curr Pharm Des2026https://conductscience.org/library/papers/40390226PubMed
40124336Tailored virus-mimicking nanoparticles mediate high transfection of pTRAIL for bystander effects in oncotherapy.Mater Today Bio2025https://conductscience.org/library/papers/40124336PubMed
40084090Basic and applied research progress of TRAIL in hematologic malignancies.Blood Sci2025https://conductscience.org/library/papers/40084090PubMed
40060291Targeting the interplay between human papillomavirus oncoproteins and hedgehog signaling: assessment of chemopreventive potential of carvacrol in cervical cancer.3 Biotech2025https://conductscience.org/library/papers/40060291PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
TNFRSF10A8797PubTator's text mininghttps://conductscience.org/library/genes/8797NCBI Gene
TNFRSF10B8795PubTator's text mininghttps://conductscience.org/library/genes/8795NCBI Gene
TNFSF108743PubTator's text mininghttps://conductscience.org/library/genes/8743NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39247341

GET https://conductscience.org/api/papers/v1/39247341/references?page=2